Limited Impact on Indian Pharma Companies Despite US Push to Cut Drug Prices
Crisil Ratings states that US President Donald Trump's executive order to reduce drug prices will have limited impact on Indian pharma companies, as most exports are low-margin…
Read More...
Read More...